| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070603 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
Genetic counselling and CDH1 gene mutation testing is indicated in families with suspected HDGC. In the absence of a satisfactory surveillance mechanism, prophylactic total gastrectomy would appear to be an appropriate therapeutic option in mutation carriers.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C.J. Moran, M. Joyce, O.J. McAnena,